PBH - Prestige Consumer Healthcare Inc Stock Price, Fair Value and News

64.61USD-0.37 (-0.57%)Delayed

Market Summary

USD64.61-0.37

Delayed

-0.57%

PBH Alerts

Big jump in Earnings (Y/Y)

PBH Stock Price

View Fullscreen

PBH RSI Chart

PBH Valuation

Market Cap

3.2B

Price/Earnings (Trailing)

15.41

Price/Sales (Trailing)

2.87

EV/EBITDA

17.97

Price/Free Cashflow

13.47

PBH Price/Sales (Trailing)

PBH Profitability

Operating Margin

55.49%

EBT Margin

24.53%

Return on Equity

12.65%

Return on Assets

6.31%

Free Cashflow Yield

7.42%

PBH Fundamentals

PBH Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-3.11%

Rev. Growth (Qtr)

-2.03%

PBH Earnings

Earnings (TTM)

209.3M

Earnings Growth (Yr)

120.56%

Earnings Growth (Qtr)

-6.76%

Breaking Down PBH Revenue

Last 7 days

-8.2%

Last 30 days

-5.0%

Last 90 days

-6.5%

Trailing 12 Months

8.4%

How does PBH drawdown profile look like?

PBH Financial Health

Current Ratio

3.2

Debt/Equity

0.68

Debt/Cashflow

0.22

PBH Investor Care

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

4.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	1.1B	1.1B	1.1B	1.1B
2022	1.1B	1.1B	1.1B	1.1B
2021	943.4M	983.2M	1.0B	1.1B
2020	963.0M	960.3M	959.6M	956.8M
2019	975.8M	954.0M	952.7M	952.8M
2018	1.0B	1.0B	1.0B	990.7M
2017	882.1M	929.1M	972.0M	1.0B
2016	806.2M	823.7M	832.7M	849.2M
2015	714.6M	761.1M	785.8M	788.4M
2014	597.4M	600.6M	614.9M	667.6M
2013	623.6M	619.1M	624.2M	608.8M
2012	441.1M	492.8M	549.1M	603.1M
2011	333.7M	357.8M	385.0M	400.7M
2010	292.6M	302.9M	313.2M	323.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Prestige Consumer Healthcare Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 07, 2024	p'pool william	acquired	-	-	3,123	see remarks
May 07, 2024	mekhail adel	acquired	-	-	3,020	evp, marketing & sales
May 07, 2024	sacco christine	acquired	-	-	6,062	chief financial officer
May 07, 2024	lombardi ronald m.	acquired	-	-	14,298	chief executive officer
May 07, 2024	zerillo jeffrey	acquired	-	-	2,116	senior vp operations
May 07, 2024	fritz mary beth	acquired	-	-	2,042	svp quality & regulatory
May 06, 2024	p'pool william	sold (taxes)	-206,220	70.00	-2,946	see remarks
May 06, 2024	fritz mary beth	acquired	-	-	3,456	svp quality & regulatory
May 06, 2024	lombardi ronald m.	acquired	-	-	85,533	chief executive officer
May 06, 2024	sacco christine	sold (taxes)	-375,410	70.00	-5,363	chief financial officer

Which funds bought or sold PBH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	Tidal Investments LLC	added	4.66	80,855	417,075	0.01%
May 16, 2024	COMERICA BANK	reduced	-18.99	-173,568	4,184,840	0.02%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-4.7	414,870	3,617,040	-%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-47.00	-489,696	827,329	-%
May 16, 2024	Virtus Investment Advisers, Inc.	unchanged	-	253,596	1,622,660	1.16%
May 15, 2024	Steward Partners Investment Advisory, LLC	reduced	-26.97	-1,983	12,771	-%
May 15, 2024	EVERGREEN CAPITAL MANAGEMENT LLC	new	-	216,447	216,447	0.01%
May 15, 2024	Squarepoint Ops LLC	reduced	-0.55	461,476	3,043,670	-%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	added	56.43	546,473	1,186,280	-%
May 15, 2024	Cutter Capital Management, LP	sold off	-100	-5,203,700	-	-%

Are Funds Buying or Selling PBH?

Are funds buying PBH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PBH

No. of Funds

PBH Alerts

Big jump in Earnings (Y/Y)

Unveiling Prestige Consumer Healthcare Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	macquarie group ltd	6.17%	3,062,581	SC 13G
Feb 14, 2024	ariel investments, llc	5.2%	2,555,777	SC 13G
Feb 13, 2024	vanguard group inc	11.60%	5,756,138	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	6.9%	3,434,500	SC 13G/A
Jan 19, 2024	blackrock inc.	18.3%	9,067,957	SC 13G/A
Feb 10, 2023	dimensional fund advisors lp	7.4%	3,674,930	SC 13G/A
Feb 09, 2023	vanguard group inc	11.61%	5,748,791	SC 13G/A
Jan 23, 2023	blackrock inc.	19.0%	9,407,577	SC 13G/A
Feb 08, 2022	dimensional fund advisors lp	6.9%	3,435,736	SC 13G/A
Jan 28, 2022	blackrock inc.	16.2%	8,111,381	SC 13G/A

Recent SEC filings of Prestige Consumer Healthcare Inc

View All Filings

Date Filed	Form Type	Document
May 15, 2024	10-K	Annual Report
May 14, 2024	8-K	Current Report
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 08, 2024	4	Insider Trading
May 08, 2024	8-K	Current Report

Peers (Alternatives to Prestige Consumer Healthcare Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	372.2B	85.6B	6.82%	-1.69%	9.67	4.35	5.68%	202.39%
MRK	332.3B	61.4B	4.65%	15.09%	144.1	5.41	6.11%	-82.30%
AMGN	167.7B	29.5B	18.35%	39.38%	44.55	5.68	12.76%	-52.47%
PFE	162.3B	57.8B	12.71%	-21.46%	129.52	2.81	76.51%	-86.81%
GILD	84.4B	27.4B	1.23%	-13.37%	174.21	3.07	1.51%	-91.32%
TEVA	18.4B	16.0B	23.52%	97.09%	-37.29	1.15	7.23%	71.10%
MID-CAP
ALKS	4.1B	1.7B	0.67%	-19.91%	9.41	2.37	54.01%	364.56%
PRGO	4.1B	4.6B	-0.70%	-10.77%	-528.11	0.89	-0.06%	94.55%
BHC	2.5B	9.0B	-21.94%	-21.03%	-5.45	0.28	10.01%	-27.45%
AMPH	2.1B	676.2M	8.56%	-0.82%	13.75	3.14	30.38%	66.04%
SMALL-CAP
TLRY	1.5B	743.2M	15.12%	-18.85%	-4.35	2.06	24.65%	80.36%
TXMD	25.8M	1.3M	18.52%	-47.17%	-3.49	19.84	-98.14%	-104.71%
ACRX	18.4M	89.6M	6.93%	25.60%	-1.29	0.19	287.27%	-129.41%
AGRX	2.5M	21.5M	2.70%	-90.89%	-0.32	0.12	66.16%	61.83%
ACOR	633.5K	115.7M	-50.00%	-97.38%	0	0.01	-2.22%	-352.48%

Prestige Consumer Healthcare Inc News

Latest updates

Prestige Consumer Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.0%	277	283	286	279	286	276	289	277	267	274	276	269	238	239	237	229	251	242	238	232	241
Cost Of Revenue	0.3%	125	125	126	125	132	125	128	117	118	119	119	110	101	100	100	96.00	107	104	101	98.00	103
Gross Profit	-3.9%	152	158	160	155	154	150	161	160	149	155	158	159	137	139	138	134	144	137	137	134	138
Operating Expenses	-2.0%	70.00	71.00	72.00	69.00	435	63.00	77.00	73.00	71.00	72.00	79.00	68.00	66.00	65.00	65.00	54.00	70.00	61.00	67.00	63.00	292
S&GA Expenses	-100.0%	-	26.00	26.00	28.00	28.00	27.00	26.00	27.00	27.00	26.00	32.00	22.00	21.00	21.00	20.00	20.00	24.00	21.00	23.00	22.00	21.00
EBITDA Margin	5605.1%	0.21*	0.00*	0.00*	0.00*	0.01*	0.32*	0.32*	0.33*	0.33*	0.31*	0.32*	0.33*	-	-	-	-	-	-	-	-	-
Interest Expenses	7.9%	-15.26	-16.57	-17.61	-17.72	119	-17.92	-16.98	-15.29	113	-16.92	-16.31	-15.08	146	-20.14	-21.27	-21.94	145	-24.27	-24.48	25.00	26.00
Income Taxes	8.1%	18.00	17.00	17.00	15.00	-58.97	16.00	16.00	16.00	9.00	15.00	14.00	19.00	5.00	13.00	7.00	14.00	13.00	12.00	11.00	12.00	-39.76
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	59.00	-	-	-	51.00	51.00	44.00	46.00	-179
EBT Margin	396.2%	0.25*	-0.08*	-0.08*	-0.08*	-0.08*	0.24*	0.24*	0.24*	0.24*	0.19*	0.20*	0.21*	-	-	-	-	-	-	-	-	-
Net Income	-6.8%	49.00	53.00	54.00	53.00	-240	52.00	51.00	55.00	52.00	50.00	45.00	58.00	36.00	41.00	45.00	44.00	37.00	38.00	33.00	34.00	-139
Net Income Margin	361.5%	0.19*	-0.07*	-0.07*	-0.07*	-0.07*	0.19*	0.19*	0.19*	0.19*	0.18*	0.18*	0.18*	-	-	-	-	-	-	-	-	-
Free Cashflow	-8.2%	64.00	69.00	60.00	47.00	56.00	53.00	55.00	57.00	60.00	64.00	58.00	68.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.6%	3,318	3,340	3,333	3,346	3,354	3,750	3,679	3,682	3,671	3,659	3,676	3,559	3,429	3,469	3,434	3,450	3,514	3,464	3,465	3,461	3,441
Current Assets	-4.8%	375	394	388	392	392	409	337	325	293	275	305	409	270	301	270	296	366	300	305	311	301
Cash Equivalents	-27.0%	46.00	64.00	60.00	55.00	58.00	86.00	42.00	36.00	27.00	21.00	43.00	164	32.00	62.00	27.00	58.00	95.00	29.00	28.00	29.00	28.00
Inventory	-6.7%	139	149	161	170	162	159	141	134	120	106	108	106	115	117	114	117	116	121	126	129	120
Net PPE	8.7%	77.00	70.00	71.00	70.00	70.00	70.00	70.00	70.00	71.00	70.00	70.00	70.00	70.00	69.00	65.00	58.00	56.00	53.00	53.00	51.00	51.00
Goodwill	0.0%	528	528	527	527	528	577	576	577	579	579	579	1.00	578	580	578	577	575	578	578	578	579
Liabilities	-4.4%	1,663	1,739	1,797	1,865	1,907	2,063	2,059	2,097	2,093	2,141	2,214	2,143	2,071	2,146	2,156	2,223	2,343	2,308	2,352	2,359	2,345
Current Liabilities	-8.2%	117	127	130	147	161	160	152	155	143	135	149	125	122	126	136	132	150	149	147	143	127
Long Term Debt	-6.1%	1,126	1,199	1,263	1,317	1,346	1,424	1,438	1,472	1,477	1,530	1,593	1,545	1,480	1,549	1,548	1,621	1,730	1,701	1,754	1,779	1,799
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	6.00	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	-	1,346	-	-	-	1,477	-	-	1,545	1,480	1,549	1,548	1,621	1,730	1,701	1,754	1,779	1,799
Shareholder's Equity	3.4%	1,655	1,601	1,536	1,480	1,447	1,687	1,620	1,585	1,578	1,518	1,462	1,416	1,358	1,323	1,278	1,227	1,171	1,156	1,113	1,102	1,096
Retained Earnings	3.8%	1,341	1,292	1,239	1,185	1,132	1,372	1,320	1,269	1,214	1,162	1,112	1,067	1,009	973	932	888	844	807	769	736	702
Additional Paid-In Capital	2.0%	567	556	552	547	535	533	524	521	516	513	507	504	500	495	494	491	488	486	484	481	479
Shares Outstanding	0.1%	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	2,816	-	-	-	2,452	-	-	-	2,799	-	-	-	1,821	-	-	-	1,738	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-6.4%	66,907	71,472	62,460	48,087	58,987	54,942	57,540	58,247	63,126	66,297	61,194	69,305	59,087	49,227	52,139	75,154	56,126	57,998	50,223	52,777	50,847
Share Based Compensation	-100.0%	-	2,449	3,688	4,146	2,649	2,433	3,466	3,857	1,708	2,234	3,219	1,878	2,599	1,588	2,892	1,464	1,962	1,780	2,521	1,381	1,278
Cashflow From Investing	-233.7%	-15,004	-4,496	-2,934	2,323	-6,358	-1,803	-2,376	-1,047	-3,293	-20,229	-231,666	-1,323	-4,896	-5,728	-9,066	-2,553	-8,265	-2,483	-3,866	-1,956	-3,341
Cashflow From Financing	-5.6%	-68,444	-64,843	-53,549	-54,179	-80,495	-10,021	-47,956	-47,374	-54,115	-67,638	50,534	63,650	-83,709	-9,044	-75,304	-111,362	20,557	-55,676	-47,022	-49,290	-45,000
Buy Backs	-	-	-	-	25,000	-	-	12,273	37,727	-	-	-	-	1,993	8,877	997	-	6,745	-	21,210	28,766	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PBH Income Statement

2024-03-31

Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022
Revenues
Total revenues	$ 1,125,357	$ 1,127,725	$ 1,086,812
Cost of Sales
Cost of sales excluding depreciation	492,786	494,883	458,942
Cost of sales depreciation	8,123	7,548	7,224
Cost of sales	500,909	502,431	466,166
Gross profit	624,448	625,294	620,646
Operating Expenses
Advertising and marketing	153,315	145,061	157,343
General and administrative	106,152	107,354	107,459
Depreciation and amortization	22,552	25,077	24,868
Goodwill and tradename impairment	0	370,217	1,057
Total operating expenses	282,019	647,709	290,727
Operating income (loss)	342,429	(22,415)	329,919
Other expense (income)
Interest expense, net	67,160	69,164	64,287
Loss on extinguishment of debt	0	0	2,122
Other (income) expense, net	(756)	2,336	1,052
Total other expense, net	66,404	71,500	67,461
Income (loss) before income taxes	276,025	(93,915)	262,458
Provision (benefit) for income taxes	66,686	(11,609)	57,077
Net income (loss)	$ 209,339	$ (82,306)	$ 205,381
Earnings (loss) per share:
Basic (in USD per share)	$ 4.21	$ (1.65)	$ 4.09
Diluted (in USD per share)	$ 4.17	$ (1.65)	$ 4.04
Weighted average shares outstanding:
Basic (in shares)	49,757	49,889	50,259
Diluted (in shares)	50,178	49,889	50,842
Comprehensive income (loss), net of tax:
Currency translation adjustments	$ (2,940)	$ (12,076)	$ (1,296)
Unrealized gain on interest rate swaps	0	0	1,819
Unrecognized net gain on pension plans	9	334	246
Net loss on termination of pension plan	0	(790)	0
Total other comprehensive (loss) income	(2,931)	(12,532)	769
Comprehensive income (loss)	206,408	(94,838)	206,150
Net sales
Revenues
Total revenues	1,125,046	1,127,618	1,086,770
Other revenues
Revenues
Total revenues	$ 311	$ 107	$ 42

PBH Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Current assets
Cash and cash equivalents	$ 46,469	$ 58,489
Accounts receivable, net of allowance of $16,377 and $20,205, respectively	176,775	167,016
Inventories	138,717	162,121
Prepaid expenses and other current assets	13,082	4,117
Total current assets	375,043	391,743
Property, plant and equipment, net	76,507	70,412
Operating lease right-of-use assets	11,285	14,923
Finance lease right-of-use assets, net	1,541	4,200
Goodwill	527,733	527,553
Intangible assets, net	2,320,583	2,341,893
Other long-term assets	5,725	3,005
Total Assets	3,318,417	3,353,729
Current liabilities
Accounts payable	38,979	62,743
Accrued interest payable	15,763	15,688
Operating lease liabilities, current portion	4,658	6,926
Finance lease liabilities, current portion	1,494	2,834
Other accrued liabilities	56,154	72,524
Total current liabilities	117,048	160,715
Long-term debt, net	1,125,804	1,345,788
Deferred income tax liabilities	403,596	380,434
Long-term operating lease liabilities, net of current portion	7,528	9,876
Long-term finance lease liabilities, net of current portion	172	1,667
Other long-term liabilities	9,185	8,165
Total Liabilities	1,663,333	1,906,645
Commitments and Contingencies – Note 18
Stockholders’ Equity
Preferred stock – $0.01 par value; Authorized – 5,000 shares; Issued and outstanding – None	0	0
Common stock – $0.01 par value; Authorized – 250,000 shares; Issued – 55,501 shares at March 31, 2024 and 54,857 shares at March 31, 2023	555	548
Additional paid-in capital	567,448	535,356
Treasury stock, at cost – 5,680 shares at March 31, 2024 and 5,165 shares at March 31, 2023	(219,621)	(189,114)
Accumulated other comprehensive loss, net of tax	(34,495)	(31,564)
Retained earnings	1,341,197	1,131,858
Total Stockholders’ Equity	1,655,084	1,447,084
Total Liabilities and Stockholders’ Equity	$ 3,318,417	$ 3,353,729

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

CEO	Mr. Ronald M. Lombardi
WEBSITE	prestigebrands.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	560

Prestige Consumer Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Prestige Consumer Healthcare Inc? What does PBH stand for in stocks?

PBH is the stock ticker symbol of Prestige Consumer Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Prestige Consumer Healthcare Inc (PBH)?

As of Fri May 17 2024, market cap of Prestige Consumer Healthcare Inc is 3.23 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers. The fair value of Prestige Consumer Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Prestige Consumer Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PBH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Prestige Consumer Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether PBH is over valued or under valued. Whether Prestige Consumer Healthcare Inc is cheap or expensive depends on the assumptions which impact Prestige Consumer Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PBH.

What is Prestige Consumer Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, PBH's PE ratio (Price to Earnings) is 15.41 and Price to Sales (PS) ratio is 2.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PBH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Prestige Consumer Healthcare Inc's stock?

In the past 10 years, Prestige Consumer Healthcare Inc has provided 0.07 (multiply by 100 for percentage) rate of return.